SCRIB-associated tumor promotion is related to the PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) pathway [47] such as aPKC that is activated in 80% of 110 breast cancer patients particularly in invasive tumors [48]. Here, SCRIB is linked to breast cancer.